Headache in long COVID as disabling condition: A clinical approach.

Autor:	Rodrigues AN; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil., Dias ARN; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil., Paranhos ACM; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil.; Tropical Medicine Center, Federal University of Pará, Belém, Pará, Brazil., Silva CC; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil., Bastos TDR; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil., de Brito BB; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil., da Silva NM; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil., de Sousa EJS; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil., Quaresma JAS; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil.; Tropical Medicine Center, Federal University of Pará, Belém, Pará, Brazil.; USP Medical School, São Paulo University, São Paulo, São Paulo, Brazil., Falcão LFM; Center for Biological Health Sciences, State University of Pará, Belém, Pará, Brazil.; USP Medical School, São Paulo University, São Paulo, São Paulo, Brazil.
Jazyk:	angličtina
Zdroj:	Frontiers in neurology [Front Neurol] 2023 Mar 23; Vol. 14, pp. 1149294. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023).
DOI:	10.3389/fneur.2023.1149294
Abstrakt:	Background and Purpose: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can exacerbate previous headache disorders or change the type of pain experienced from headaches. This study aimed to investigate the clinical features of Long COVID headaches. Method: This was a cross-sectional, descriptive, and analytical observational study that included 102 patients (with previous headache, n = 50; without previous headache, n = 52) with long COVID and headache complaints. The Migraine Disability Assessment Test and Visual Analog Pain Scale were used to collect participants' headache data according to a standardized protocol. Results: The patients in this study who reported experiencing headaches before COVID-19 had longer headache duration in the long COVID phase than that in the pre-long COVID phase ( p = 0.031), exhibited partial improvement in headache symptoms with analgesics ( p = 0.045), and had a duration of long COVID of <1 year ( p = 0.030). Patients with moderate or severe disability and those classified as having severe headaches in the long COVID phase were highly likely to develop chronic headaches. Hospital admission [odds ratio (OR) = 3.0082; 95% confidence interval (95% CI): 1.10-8.26], back pain (OR = 4.0017; 95% CI: 1.13-14.17), insomnia (OR = 3.1339; 95% CI: 1.39-7.06), and paraesthesia (OR = 2.7600; 95% CI: 1.20-6.33) were associated with headache in these patients. Conclusion: Headache is a disabling condition in patients with long COVID-19, exacerbating the conditions of those with headaches prior to contracting COVID-19. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer LD declared a shared affiliation with the authors JQ and LF at the time of review. (Copyright © 2023 Rodrigues, Dias, Paranhos, Silva, Bastos, Brito, da Silva, de Sousa, Quaresma and Falcão.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu